Диссертация (Токсические фосфорные некрозы лицевого черепа), страница 40
Описание файла
Файл "Диссертация" внутри архива находится в папке "Токсические фосфорные некрозы лицевого черепа". PDF-файл из архива "Токсические фосфорные некрозы лицевого черепа", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве МГМУ им. Сеченова. Не смотря на прямую связь этого архива с МГМУ им. Сеченова, его также можно найти и в других разделах. , а ещё этот архив представляет собой докторскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени доктора медицинских наук.
Просмотр PDF-файла онлайн
Текст 40 страницы из PDF
JOral Maxillofac Surg. 1994 Jan;52(1):26-33; discussion 33-4.245. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: riskfactors, prediction of risk using serum CTX testing, prevention, and treatment. J OralMaxillofac Surg. 2007 Dec;65(12):2397-410.246. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposedbone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, andtreatment. J Oral Maxillofac Surg. 2005;63:1567-75.247. Marx RE.
Oral and intravenous bisphosphonate-induced osteonecrosis of thejaws. History, etiology, prevention, and treatment. Quintessence Publishing Co Inc;2007. p. 9–96.322248. Marx RE: Chronic osteomyelitis of the jaws. Oral Maxillofac Surg Clin NorthAm 3:367, 1991249. Marx RE: Pamidronate (Aredia) and zoledronate (Zometa) induced avascularnecrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003, 61:1115-1117.250. Marx RE: Uncovering the cause of “phossy jaw” circa 1858 to 1906: Oral andmaxillofacial surgery closed case file—Case closed.
J Oral Maxillofac Surg 66:2356,2008251. Marx. R. Diffuse sclerosing osteomyelitis of the mandible: its characteristics andpossible relationship tosynovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO)syndrome. J Oral Maxillofac Surg. 1996 Oct;54(10):; discussion 1199-200.252. Melo M.D., Obeid G.
Osteonecrosis of the jaws in patients with a history ofreceiving bisphosphonate therapy: Strategies for prevention and early recognition // JAm Dent Assoc 2005;136;1675-1681253. Melo M.D., Obeid G. Osteonecrosis of the Maxilla in a Patient with a History ofBisphosphonate Therapy // J Can Dent Assoc 2005; 71(2):111–3254.
Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history ofreceiving bisphosphonate therapy: strategies for prevention and early recognition. J AmDent Assoc. 2005;136:1675-81.255. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. Jaw bone necrosiswithout previous dental extractions associated with the use of bisphosphonates(pamidronate and zoledronate): a four-case report. J Oral Pathol Med. 2005;34: 613-7.256. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB.Managing the care of patients with bisphosphonate-associated osteonecrosis: anAmerican Academy of Oral Medicine position paper (published correction appears inJADA 2006;137([1]):26.). JADA 2005;136(12):1658-68.257. MiglioratiCA,SchubertMM,PetersonDE,SenedaLM.Bisphosphonateassociated osteonecrosis of mandibular and maxillary bone: anemerging oral complication of supportive cancer therapy.
Cancer. 2005;104:83-93.[PMID: 15929121]323258. Migliorati CA, Siegel MA, Elting LS: Bisphosphonate-associated osteonecrosis:A long-term complication of bisphosphonate treatment. Lancet 2006;7:508–514.259. Migliorati CA: Bisphosphanates and oral cavity avascular bone necrosis. J ClinOncol 2003, 15:4253-4254. Marx RE: Pamidronate (Aredia) and zoledronate (Zometa)induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg2003, 61:1115-1117.260.
Mignogna M.D., Russo L.L., Fedele S., Ciccarelli R., Muzio L.L. Osteonecrosisof the Jaws Associated With Bisphosphonate Therapy // JCO Mar 20 2006: 1475-1477.261. Miles AE. Phosphorus necrosis of the jaw: "phossy jaw". Br Dent J1972;133:203-206.262. Miltner, L. J., and Wblfe, J.
J.: Treatment of Suppurative Osteomyelitis of theMandible, Surg. Gynec. Obstet. 59: 226, 1934.263. Monteleone, L., and Hagy, D. M.: Garre’s Osteomyelitis, J. Oral Burg. 20: 423431, 1962.264. Montonen M, Iizuka T, Hallikainen D, Lindqvist C. Decortication in thetreatment of diffuse sclerosing osteomyelitis of the mandible. Retrospective analysis of41 cases between 1969 and 1990. Oral Surg Oral Med Oral Pathol.
1993 Jan;75(1):5-11.265. Montonen M, Kalso E, Pylkkaren L, et al: Disodium clodronate in the treatmentof diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg30:313, 2001266. Mowlem, R. : Osteomyelitis of the Jaw, Proc. Roy. Sot. Med. 38: 452, 1944-45.267. Mowlem, R.: Surgery and Penicillin in Mandibular Infection, Brit. Med.
J. 1: 517,1944.268. Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, ZhangD, Barbier A, Suda T: A possible mechanism of the specific action of bisphosphonateson osteoclasts — tiludronate preferentially affects polarized osteoclasts having ruffledborders. Bone 1995, 17:137-144.269. Nagashima M, Sakai A, Uchida S, Tanaka S, Tanaka M, Nakamura T.Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury324by reducing terminal differentiation of osteoblasts in the mouse femur. Bone2005;36:502-11.270.
Nancollas GH, Tang R, Gulde S, et al. Novel insights into actions ofbisphosphonates on bone: differences in interactions with hydroxyapatite. Bone.38(2006) 617—627271. Nandakumar H, Shankaramba KB. Massive sequestration of the upper jaw: a casereport. Br J OralMaxillofac Surg 1990;28:55–56.272. Napoli JA, Donegan JO. Aspergillosis and necrosis of the maxilla: a case report. JOral MaxillofacSurg 1991;49:532–534.273. Nortjé CJ, Wood RE, Grotepass F. Periostitis ossificans versus Garrè'sosteomyelitis: Part II: Radiologic analysis of 93 cases in the jaws.
Oral Surg Oral MedOral Pathol. 1988;66:249–260274. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severelysuppressed bone turnover: a potential complication of alendronate therapy. J ClinEndocrinol Metab 2005;90:1294-301.275. Ott SM. Long-term safety of bisphosphonates. J Clin Endocrinol Metab2005;90:1897-9.276. Owotade FJ, Ugboko VI, Kolude B. Herpes zoster infection of the maxilla: casereport. J OralMaxillofac Surg 1999;57:1249–1251. [PubMed: 10513873]277.
Panders AK, Hadders HN. Chronic sclerosing inflammations of the jaw. ORALSURG ORAL MED ORAL PATHOL 1970; 30~396-412.278. Pastor-Zuazaga D, Garatea-Crelgo J, Martino-Gorbea R, Etayo-Pe´rez A,Sebastia´n-Lo´pez C. Osteonecrosis of the jaws and bisphosphonates. Report of threecases. Med Oral Patol Oral Cir Bucal. 2006;11:E76-9. [PMID: 16388300])279.
Patel S., Lyons A., Hosking D. Drugs used in the treatment of metabolic bonedisease. Clinical pharmacology and therapeutic use// Drugs. – 1993. – Vol. 46. – P. –594–517.280. Pautke C, Tischer T, Neff A, Horch HH, Kolk A. In vivo tetracycline labeling ofbone: an intraoperative aid in the surgical therapy ofosteoradionecrosis of the mandible.325Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Dec;102(6):e10-3.
Epub 2006Sep 26.281. Pell, G. J., Shafer, W. G., Gregory, G. T., Ping, R. T., and Spear, L. B.: Garre’sOsteomyelitis of the Mandible: Report of Case, J. Oral Surg. 13: 248-252 1955282. Perriman A, Uthman A. Periostitis ossificans. Br J Oral Surg. 1972Nov;10(2):211-6.283. Peters E, Lovas GL, Wysocki GP. Lingual mandibular sequestration andulceration. Oral Surg Oral Med Oral Pathol 1993;75(6): 739-743.284. Phal P.M., Myall R.W.T., Assael L.A., Weissman J.L. Imaging Findings ofBisphosphonate-Associated Osteonecrosis of the Jaws // AJNR Am J Neuroradiol28:1139–45285. Philipone E. Nonhealing extraction site. Gen Dent. 2005;53:161, 163. [PMID:15833019]286. Pires FR, Miranda A, Cardoso ES, Cardoso AS, Fregnani ER, Pereira CM, et al.Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy.Oral Dis.
2005;11:365-9. [PMID: 16269027]287. Polascik T.J. Bisphosphonates in oncology: evidence for the prevention ofskeletal events in patients with bone metastases // Drug Design, Development andTherapy 2009:3:27-40288. PolizzottoMN,CousinsV,SchwarerAP.Bisphosphonate-associatedosteonecrosis of the auditory canal [Letter].
Br J Haematol. 2006;132:114. [PMID:16371027]289. Ponte Fernández N, Estefania Fresco R, Aguirre Urizar JM. Bisphosphonates andoral pathology I. General and preventive aspects. Med Oral Patol Oral Cir Bucal. 2006Aug 1;11(5):E396-400.290.
Pozzi S, Marcheselli R, Sacchi S, et al. Analysis of frequency and risk factors fordeveloping bisphosphonate associated necrosis of the jaw. Blood. (American Society ofHematology Annual Meeting Abstracts) 106:5057, 2005291. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaw. Med JAust. 2005;182:417-8. [PMID: 15850440]326292. Ramon Y, Oberman M, Horowitz I, Freedman A. Extensive maxillaryequestration resulting fromrhinocerebral mucormyocosis.
